Page last updated: 2024-11-01

omeprazole and Myositis

omeprazole has been researched along with Myositis in 2 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Myositis: Inflammation of a muscle or muscle tissue.

Research Excerpts

ExcerptRelevanceReference
"Polymyositis occurring in patients treated with omeprazole has been signalled as a possible adverse drug reaction (ADR) by the New Zealand Intensive Medicines Monitoring Programme (IMMP) and the WHO Collaborating Centre for International Drug Monitoring: the Uppsala Monitoring Centre (UMC)."4.83Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? ( Clark, DW; Strandell, J, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Visruthan, NK1
Boo, PK1
Kader, A1
Ping, CH1
Ong, C1
Clark, DW1
Strandell, J1

Reviews

1 review available for omeprazole and Myositis

ArticleYear
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Enzyme Inhibitors;

2006

Other Studies

1 other study available for omeprazole and Myositis

ArticleYear
Omeprazole-induced myositis in a child receiving triple therapy for Helicobacter pylori infection.
    Journal of pediatric gastroenterology and nutrition, 2012, Volume: 55, Issue:3

    Topics: Adolescent; Anti-Ulcer Agents; Helicobacter Infections; Humans; Male; Myositis; Omeprazole

2012